33 results on '"Jevsevar, David S."'
Search Results
2. Making a Joint Decision Regarding the Timing of Surgery for Elective Arthroplasty Surgery After Being Infected With COVID-19: A Systematic Review
3. Do Patient Engagement Platforms in Total Joint Arthroplasty Improve Patient-Reported Outcomes?
4. Perioperative Antibiotic Prophylaxis: Single and 24-Hour Antibiotic Dosages are Equally Effective at Preventing Periprosthetic Joint Infection in Total Joint Arthroplasty
5. Generalized Anxiety Disorder: A Modifiable Risk Factor for Pain Catastrophizing After Total Joint Arthroplasty
6. Metric Selection, Metric Targets, and Risk Adjustment Should be Considered in the Design of Gainsharing Models for Bundled Payment Programs in Total Joint Arthroplasty
7. Does Productivity-Based Physician Compensation Affect Surgical Rates for Elective Arthroplasty Surgery?
8. After the COVID-19 Pandemic: Returning to Normalcy or Returning to a New Normal?
9. Does the Impact of Joint Arthroplasty Extend Beyond the Patient? The Effect of Total Joint Arthroplasty on Patient’s Significant Others
10. A SANE Approach to Outcome Collection? Comparing the Performance of Single- Versus Multiple-Question Patient-Reported Outcome Measures After Total Hip Arthroplasty
11. What Happens to Unused Opioids After Total Joint Arthroplasty? An Evaluation of Unused Postoperative Opioid Disposal Practices
12. Do Medicare’s Patient–Reported Outcome Measures Collection Windows Accurately Reflect Academic Clinical Practice?
13. A One-Question Patient-Reported Outcome Measure Is Comparable to Multiple-Question Measures in Total Knee Arthroplasty Patients
14. Defining and Optimizing Value in Total Joint Arthroplasty From the Patient, Payer, and Provider Perspectives
15. Skilled Nursing Facility Placement Process After Total Hip and Total Knee Arthroplasty: Revised Rating System and Opportunities for Intervention
16. Preoperative Patient-Reported Outcomes and Clinical Characteristics as Predictors of 90-Day Cost/Utilization and Complications
17. Are Medicare's Nursing Home Compare Ratings Accurate Predictors of 90-Day Complications, Readmission, and Bundle Cost for Patients Undergoing Primary Total Joint Arthroplasty?
18. Practical Implications of Value-Based Care in the Setting of Ambulatory Surgery Centers
19. Basics of Orthopaedic Commercial and Government Bundling
20. Patient Outcomes After Total Knee Arthroplasty in Patients Older Than 80 Years
21. The Efficacy of Tranexamic Acid in Total Hip Arthroplasty: A Network Meta-analysis
22. Tranexamic Acid Use in Total Joint Arthroplasty: The Clinical Practice Guidelines Endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society
23. The Efficacy of Tranexamic Acid in Total Knee Arthroplasty: A Network Meta-Analysis
24. The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis
25. Laxity Profiles in the Native and Replaced Knee—Application to Robotic-Assisted Gap-Balancing Total Knee Arthroplasty
26. The Cost-Effectiveness of Total Hip Arthroplasty in Patients 80 Years of Age and Older
27. Costs and Risk Factors for Hospital Readmission After Periprosthetic Knee Fractures in the United States
28. Do Aggregate Socioeconomic Status Factors Predict Outcomes for Total Knee Arthroplasty in a Rural Population?
29. Predicting the Incremental Hospital Cost of Adverse Events Among Medicare Beneficiaries in the Comprehensive Joint Replacement Program During Fiscal Year 2014
30. The Incremental Hospital Cost and Length-of-Stay Associated With Treating Adverse Events Among Medicare Beneficiaries Undergoing THA During Fiscal Year 2013
31. The Incremental Hospital Cost and Length-of-Stay Associated With Treating Adverse Events Among Medicare Beneficiaries Undergoing TKA
32. Erratum to “2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective” [The Journal of Arthroplasty 38 (2023) 2193-2201]
33. Response to Letter to the Editor on “The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.